Skip to content
by Legal Desire
20 November 2026

Linklaters advises banking syndicate on US$5.5bn SEC-registered bond issuances by Novartis

Advising firms

Deal team

8 lawyers named
LawyerFirmSeniorityPracticeOffice
Marco Carbonare Lead Linklaters Partner Corporate/M&A Not stated
Kevin Roy Lead Linklaters Counsel Corporate/M&A Not stated
Alexander Auster Linklaters Associate Corporate/M&A Not stated
Omer Harel Linklaters Counsel Tax Not stated
Alexander Gatlin Linklaters Associate Corporate/M&A Not stated
Marianna Troia Linklaters Associate Corporate/M&A Not stated
Helena Obenheimer Linklaters Associate Capital markets Not stated
Young Jin Kim Linklaters Associate Tax Not stated

5 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.

REGISTER FREE SIGN IN

Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.

Stated terms

Stated value
USD 5.50bn (US$5.5bn)
What the figure measures
Issue size
Client
global banking syndicateUnderwriters
Counterparties
Novartis Capital Corporation (Issuer)
Novartis AG (Issuer)